期刊文献+

十一酸睾酮改善维持性血液透析男性患者性生活质量的随机对照试验

A randomized controlled trial of testosterone undecanoate for improving quality of sex life of the male continuous hemodialysis patients
下载PDF
导出
摘要 目的了解十一酸睾酮(TU)在改善维持性血液透析男性患者性生活质量方面的作用及其安全性和耐受性。方法 70例血清睾酮低于260 ng/dl的维持性血透男性患者随机(随机数字表法)分为观察组和对照组,观察组除了常规血透外加用口服TU(安特尔)80 mg/早、40 mg/晚,2周后改为40 mg早晚两次,疗程6个月;对照组仅常规血透,检测血清性激素水平(FSH、LH、E2、PRL、P、T)变化及IIEF-5评分变化。结果观察组经TU治疗后T(273.72±86.52)ng/dl高于对照组(212.36±69.10)ng/dl(P<0.05),IIEF评分优于对照组,雌性激素水平、排尿困难、下肢水肿、血PSA两组均无差异(P>0.05)。结论 TU能明显改善维持性血液透析男性患者性生活质量,具有良好的安全性和耐受性。 Objective To study the effectiveness, safety and tolerance of testosterone undecanoate (TU) in improving quality of sex life of the male continuous hemodialysis patients. Methods Seventy male continuous hemodialysis patients whose serum total testosterone(T) level was lower than 260ng/dl were randomized into two groups. The treatment group was treated with routine hemodialysis and TU (80 mg/morning and 40 mg/night, after two weeks it was changed to 40 mg/morning and 40 mg/night) and the control group with routine hemodialysis alone. The study was continued for six months. Serum sex hormone of the patients was examined and the international index of erectile function (IIEF) was assessed. Results The T of the treatment group (273.72 ± 86. 52)ng/dl was significantly higher than those of the control group (212. 36 ±69. 10)ng/dl ( P 〈 0. 05 ), and the IIEF scores was also significantly higher than those of the control group. FSH,LH,E2,PRL.P level were no significant differences between both groups. There were no significant differences in adverse effects between both groups. Conclusion TU can improve the quality of sex life of the male continuous hemedialysis patients. There is a satisfactory tolerances and few adverse reactions.
出处 《中国临床新医学》 2010年第9期820-822,共3页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 南宁市科技攻关项目(编号:ZC200803C)
关键词 十一酸睾酮 性生活质量 维持性血液透析 男性患者 Testosterone undecanoate Quality of sex life Continuous hemodlalysis Male patients
  • 相关文献

参考文献5

二级参考文献20

  • 1夏同礼,孔祥田.我国成人良性前列腺增生的发生与组织形态特征[J].中华泌尿外科杂志,1993,14(6):415-417. 被引量:20
  • 2Bhasin S, Bagatell CJ, Bremner WJ, et al. Issues in testosterone replacement in older men[ J ]. J Clin Endocrinol Metab,1998; 83 : 3435 - 3448.
  • 3Gray A, Feldman HA, McKinley JB, et al. Age disease and changing sex hormone levels in middle - aged men: results of the Massachusetts Male Aging Study[ J ]. J Clin Endocrinol Metab,1991 ; 73 : 1016 - 1025.
  • 4Bagatell C J,Bremner WJ. Androgen and progestagen effects on plasma lipids[J]. Prog Cardiovasc Dis, 1995;38:255 -271.
  • 5Morales A, Johnston B, Heaton JPW, et al. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes [ J ]. J Urol, 1997;157:849 - 854.
  • 6Tenover JS. Effects of testosterone supplementation in the aging male [J]. J Clin Endocrinal Metab, 1992; 75:1092 -1098.
  • 7马腾骧.良性前列腺增生的基础知识.见:顾方六主编.现代前列腺病学.北京:人民军医出版社,2002:53-72
  • 8Barry MJ,Boyle P,Garraway M,et al.Epidemiology and natural history of BPH.In:Cockett ATK,Aso Y,Denis LJ,eds.Proceedings of Second International Consultation on Benign Prostatic Hyperplasia.Jersey SCI,1993:19-34
  • 9Gooren LJG.A ten-year safety study of the oral androgen testosterone undecanoate.J Androl 1994;15:212-215
  • 10Semple CG;Beastall GH et al.The pituitary-testicular axis of uraemic subjects on haemodialysis and continuous ambulatory peritoneal dialysis.Acta Endocrinologica[Acta Endocrinol(Copenh)] 1982 Nov;Vol.101(3),pp.464-467.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部